Utah Retirement Systems Pfizer Inc Transaction History

Utah Retirement Systems

$8.85 Billion
Q4 2024

A detailed history of Utah Retirement Systems transactions in Pfizer Inc stock. As of the latest transaction made, Utah Retirement Systems holds 940,568 shares of PFE stock, worth $24.2 Million. This represents 0.28% of its overall portfolio holdings.

Number of Shares

940,568

Previous 937,768 0.3%

Holding current value

$24.2 Million

Previous $27.1 Million 8.05%

% of portfolio

0.28%

Previous 0.31%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$24.8 - $30.19 $69,440 - $84,532	2,800 Added 0.3%	940,568 $25 Million
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $96,950 - $109,865	3,500 Added 0.37%	937,768 $27.1 Million
Q2 2024 Aug 14, 2024	SELL	$25.26 - $29.6 $1.15 Million - $1.34 Million	-45,400 Reduced 4.63%	934,268 $26.1 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $18,123 - $20,811	-700 Reduced 0.07%	979,668 $27.2 Million
Q4 2023 Feb 14, 2024	BUY	$26.13 - $33.94 $151,554 - $196,852	5,800 Added 0.6%	980,368 $28.2 Million
Q3 2023 Nov 14, 2023	BUY	$32.09 - $37.51 $141,196 - $165,044	4,400 Added 0.45%	974,568 $32.3 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $41.79 $1.33 Million - $1.54 Million	-36,900 Reduced 3.66%	970,168 $35.6 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $122,109 - $158,968	3,100 Added 0.31%	1,007,068 $41.1 Million
Q4 2022 Feb 15, 2023	SELL	$41.75 - $54.5 $392,450 - $512,300	-9,400 Reduced 0.93%	1,003,968 $51.5 Million
Q3 2022 Nov 14, 2022	BUY	$43.76 - $53.42 $218,800 - $267,100	5,000 Added 0.5%	1,013,368 $44.3 Million
Q2 2022 Aug 16, 2022	BUY	$46.53 - $55.17 $549,054 - $651,006	11,800 Added 1.18%	1,008,368 $52.9 Million
Q1 2022 May 13, 2022	SELL	$45.75 - $56.69 $754,875 - $935,385	-16,500 Reduced 1.63%	996,568 $51.6 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $95,036 - $140,875	2,300 Added 0.23%	1,013,068 $59.8 Million
Q3 2021 Nov 16, 2021	SELL	$39.25 - $50.42 $2.1 Million - $2.7 Million	-53,600 Reduced 5.04%	1,010,768 $43.5 Million
Q2 2021 Aug 16, 2021	SELL	$35.91 - $40.68 $147,231 - $166,788	-4,100 Reduced 0.38%	1,064,368 $41.7 Million
Q1 2021 May 17, 2021	SELL	$33.49 - $37.77 $1.57 Million - $1.77 Million	-46,900 Reduced 4.2%	1,068,468 $38.7 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $1.6 Million - $2.03 Million	47,700 Added 4.47%	1,115,368 $41.1 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $228,600 - $268,200	7,200 Added 0.68%	1,067,668 $39.2 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $36,144 - $43,848	-1,200 Reduced 0.11%	1,060,468 $34.7 Million
Q1 2020 May 15, 2020	SELL	$27.03 - $38.62 $5,406 - $7,723	-200 Reduced 0.02%	1,061,668 $34.7 Million
Q4 2019 Feb 12, 2020	BUY	$32.92 - $37.36 $125,096 - $141,968	3,800 Added 0.36%	1,061,868 $41.6 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $84,474 - $109,538	-2,600 Reduced 0.25%	1,058,068 $38 Million
Q2 2019 Aug 14, 2019	SELL	$36.98 - $41.52 $840,629 - $943,832	-22,732 Reduced 2.1%	1,060,668 $45.9 Million
Q1 2019 May 15, 2019	BUY	$37.5 - $41.2 $49,012 - $53,848	1,307 Added 0.12%	1,083,400 $46 Million
Q4 2018 Feb 08, 2019	BUY	$38.47 - $43.86 $96,175 - $109,650	2,500 Added 0.23%	1,082,093 $47.2 Million
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $165,456 - $200,688	4,800 Added 0.45%	1,079,593 $47.6 Million
Q2 2018 Aug 10, 2018	SELL	$32.98 - $35.16 $923,439 - $984,479	-28,000 Reduced 2.54%	1,074,793 $39 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $54,247 - $62,934	1,700 Added 0.15%	1,102,793 $39.1 Million
Q4 2017 Feb 14, 2018	BUY	$33.26 - $35.29 $495,573 - $525,821	14,900 Added 1.37%	1,101,093 $39.9 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $33.7 Million - $37.1 Million	1,086,193	1,086,193 $38.8 Million

Others Institutions Holding PFE

# of Institutions

3,375

Shares Held

3.69B

Call Options Held

106M

Put Options Held

123M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $144B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Utah Retirement Systems, based on Form 13F filings with the SEC.

News

Stay updated on Utah Retirement Systems with notifications on news.

Account

Utah Retirement Systems Pfizer Inc Transaction History